Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents

Dianne L. Newton, Hans J. Hansen, Huaitian Liu, Dale Ruby, Mihail S. Iordanov, Bruce E. Magun, David M. Goldenberg, Susanna M. Rybak

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Targeting CD22 on human B-cells with a monoclonal antibody conjugated to a cytotoxic RNAse causes potent and specific killing of the lymphoma cells in vitro. This translates to anti-tumor effects in human lymphoma models in SCID mice. RNA damage caused by RNAses could be an important alternative to standard DNA damaging chemotherapeutics. Moreover, targeted RNAses may overcome problems of toxicity and immunogenicity associated with plant or bacterial toxin containing immunotoxins.

Original languageEnglish (US)
Pages (from-to)79-86
Number of pages8
JournalCritical Reviews in Oncology/Hematology
Volume39
Issue number1-2
DOIs
StatePublished - 2001

Fingerprint

B-Cell Lymphoma
Ribonucleases
Lymphoma
RNA
Bacterial Toxins
Immunotoxins
SCID Mice
B-Lymphocytes
Monoclonal Antibodies
DNA
Neoplasms
In Vitro Techniques

Keywords

  • Antibody
  • Apoptosis
  • Cancer
  • Immunotoxin
  • Ribonuclease

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Newton, D. L., Hansen, H. J., Liu, H., Ruby, D., Iordanov, M. S., Magun, B. E., ... Rybak, S. M. (2001). Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents. Critical Reviews in Oncology/Hematology, 39(1-2), 79-86. https://doi.org/10.1016/S1040-8428(01)00116-0

Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents. / Newton, Dianne L.; Hansen, Hans J.; Liu, Huaitian; Ruby, Dale; Iordanov, Mihail S.; Magun, Bruce E.; Goldenberg, David M.; Rybak, Susanna M.

In: Critical Reviews in Oncology/Hematology, Vol. 39, No. 1-2, 2001, p. 79-86.

Research output: Contribution to journalArticle

Newton, DL, Hansen, HJ, Liu, H, Ruby, D, Iordanov, MS, Magun, BE, Goldenberg, DM & Rybak, SM 2001, 'Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents', Critical Reviews in Oncology/Hematology, vol. 39, no. 1-2, pp. 79-86. https://doi.org/10.1016/S1040-8428(01)00116-0
Newton, Dianne L. ; Hansen, Hans J. ; Liu, Huaitian ; Ruby, Dale ; Iordanov, Mihail S. ; Magun, Bruce E. ; Goldenberg, David M. ; Rybak, Susanna M. / Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents. In: Critical Reviews in Oncology/Hematology. 2001 ; Vol. 39, No. 1-2. pp. 79-86.
@article{602a99f4068f47d28c252510b0db8ab2,
title = "Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents",
abstract = "Targeting CD22 on human B-cells with a monoclonal antibody conjugated to a cytotoxic RNAse causes potent and specific killing of the lymphoma cells in vitro. This translates to anti-tumor effects in human lymphoma models in SCID mice. RNA damage caused by RNAses could be an important alternative to standard DNA damaging chemotherapeutics. Moreover, targeted RNAses may overcome problems of toxicity and immunogenicity associated with plant or bacterial toxin containing immunotoxins.",
keywords = "Antibody, Apoptosis, Cancer, Immunotoxin, Ribonuclease",
author = "Newton, {Dianne L.} and Hansen, {Hans J.} and Huaitian Liu and Dale Ruby and Iordanov, {Mihail S.} and Magun, {Bruce E.} and Goldenberg, {David M.} and Rybak, {Susanna M.}",
year = "2001",
doi = "10.1016/S1040-8428(01)00116-0",
language = "English (US)",
volume = "39",
pages = "79--86",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents

AU - Newton, Dianne L.

AU - Hansen, Hans J.

AU - Liu, Huaitian

AU - Ruby, Dale

AU - Iordanov, Mihail S.

AU - Magun, Bruce E.

AU - Goldenberg, David M.

AU - Rybak, Susanna M.

PY - 2001

Y1 - 2001

N2 - Targeting CD22 on human B-cells with a monoclonal antibody conjugated to a cytotoxic RNAse causes potent and specific killing of the lymphoma cells in vitro. This translates to anti-tumor effects in human lymphoma models in SCID mice. RNA damage caused by RNAses could be an important alternative to standard DNA damaging chemotherapeutics. Moreover, targeted RNAses may overcome problems of toxicity and immunogenicity associated with plant or bacterial toxin containing immunotoxins.

AB - Targeting CD22 on human B-cells with a monoclonal antibody conjugated to a cytotoxic RNAse causes potent and specific killing of the lymphoma cells in vitro. This translates to anti-tumor effects in human lymphoma models in SCID mice. RNA damage caused by RNAses could be an important alternative to standard DNA damaging chemotherapeutics. Moreover, targeted RNAses may overcome problems of toxicity and immunogenicity associated with plant or bacterial toxin containing immunotoxins.

KW - Antibody

KW - Apoptosis

KW - Cancer

KW - Immunotoxin

KW - Ribonuclease

UR - http://www.scopus.com/inward/record.url?scp=0034966335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034966335&partnerID=8YFLogxK

U2 - 10.1016/S1040-8428(01)00116-0

DO - 10.1016/S1040-8428(01)00116-0

M3 - Article

C2 - 11418304

AN - SCOPUS:0034966335

VL - 39

SP - 79

EP - 86

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 1-2

ER -